Liver and peripheral blood concentration ratio (L/P) as a marker of postmortem drug redistribution: A literature review

Forensic Science, Medicine, and Pathology

Volumn 10, Issue 1, 2014, Pages 91-96

  McIntyre, Iain M ^a  

^a UNIVERSITY OF CALIFORNIA COOPERATIVE EXTENSION   (United States)

Author keywords

Liver; Peripheral blood; Postmortem redistribution; Postmortem toxicology; Ratio

Indexed keywords

ANTIDEPRESSANT AGENT; DRUG;

AUTOPSY; BLOOD; CHEMISTRY; FORENSIC MEDICINE; HUMAN; LIVER; METHODOLOGY; PHARMACOKINETICS; POSTMORTEM CHANGE; REVIEW; TISSUE DISTRIBUTION;

ANTIDEPRESSIVE AGENTS; AUTOPSY; FORENSIC MEDICINE; HUMANS; LIVER; PHARMACEUTICAL PREPARATIONS; PHARMACOKINETICS; POSTMORTEM CHANGES; TISSUE DISTRIBUTION;

EID: 84893685431     PISSN: 1547769X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12024-013-9503-x     Document Type: Review

References (52)

1. Baselt RC. Disposition of toxic drugs and chemicals in man. 9th ed. Foster City: Biomedical Publications; 2011.
2. Cook J, Braithwaite RA, Hale KA. Estimating antemortem drug concentrations from postmortem blood samples: the influence of postmortem redistribution. J Clin Path. 2000;53: 282-5.
3. Pounder JD, Jones GR. Post-mortem drug redistribution-a toxicological nightmare. Forensic Sci Int. 1990;45: 253-63.
4. Prouty RW, Anderson WH. The forensic science implications of site and temporal influences on postmortem blood-drug concentrations. J Forensic Sci. 1990;35: 243-70.
5. Dalpe-Scott M, Degouffe M, Garbutt D, Drost M. A comparison of drug concentrations in postmortem cardiac and peripheral blood in 320 cases. Can Soc For Sci J. 1995;28: 113-21.
6. Leiken JB, Watson WA. Post-mortem toxicology: what the dead can and cannot tell us. ClinTox. 2003;41: 47-56.
7. Repetto MR, Repetto M. Habitual, toxic and lethal concentrations of 103 drugs of abuse in humans. Clin Tox. 1997;35: 1-9.
8. Musshoff F, Padosch S, Steinborn S, Madea B. Fatal blood and tissue concentrations of more than 200 drugs. Forensic Sci Int. 2004;142: 161-210.
9. Winek C, Wahba W, Winek C, Balzer T. Drug and chemical blood-level data. Forensic Sci Int. 2001;122: 107-23.
10. Ferner RE. Post-mortem clinical toxicology. Br J Clin Pharm. 2008;66: 430-43.
11. McIntyre IM, Sherrard J, Lucas J. Postmortem carisoprodol and meprobamate concentrations in blood and liver: lack of significant distribution. J Anal Tox. 2012;36: 177-81.
12. Moore K, Sina SJ, Jones R, Selby DM, Levin B, Smith ML. Tissue distribution of tramadol and metabolites in an overdose fatality. Am J Forensic Med Pathol. 1999;20: 98-100.
13. Pélessier-Alicot AL, Gaulier JM, Champsaur P, Marquet P. Mechanisms underlying postmortem redistribution of drugs: a review. J Anal Tox. 2003;27: 533-43.
14. Anderson D, Reed S, Lintamoot J, Kegler S, deQuintana S, Sandburg M, Muto J. A first look at duloxetine in a postmortem laboratory. J Anal Tox. 2006;30: 576-580.
15. Anderson D, Fritz K, Muto J. Oxycontin: the concept of a "ghost pill" and the postmortem tissue distribution of oxycodone in 36 cases. J Anal Tox. 2002;26: 448-59.
16. Anderson D, Fritz K. Quetiapine (seroquel) concentrations in seven postmortem cases. J Anal Tox. 2000;24: 300-4.
17. Kirkton C, McIntyre IM. Therapeutic and toxic concentrations of mirtazapine. J Anal Tox. 2006;30: 687-91.
18. Pounder DJ, Adams E, Fuke C, Langford AM. Site to site variability of postmortem drug concentrations in liver and lung. J Forensic Sci. 1996;41: 927-32.
19. Molina DK, Hargrove VM. Should postmortem subclavian blood be considered a peripheral or central sample? Am J Forensic Pathol. 2013;34: 155-8.
20. DeMartinas BS, dePaula CMC, Moreira HT, Martin CCS. Alcohol distribution in different postmortem body fluids. Hum Exp Toxicol. 2005;25: 93-7.
21. Pounder DJ, Owen V, Quigley C. Postmortem changes in blood amitriptyline concentration. Am J Forensic Med Path. 1994;15: 224-30.
22. Vermuelen T. Distribution of paroxetine in three postmortem cases. J AnalTox. 1998;22: 541-4.
23. Rodda KE, Drummer OH. The redistribution of selected anti-psychotic drugs in post-mortem cases. Forensic Sci Int. 2006;164: 235-9.
24. Parker DR, McIntyre IM. Case studies of postmortem quetiapine: therapeutic or toxic concentrations? J Anal Tox. 2005;29: 407-12.
25. Levine B, Ramcharitar V, Smialek JE. Tramadol distribution in four postmortem cases. Forensic Sci Int. 1997;86: 43-8.
26. McIntyre IM, King CV, Cordner SM, Drummer OH. Postmortem clomipramine: therapeutic or toxic concentrations? J Forensic Sci. 1994;39: 486-93.
27. Rohrig TP, Prouty RH. Fluoxetine overdose: a case report. J Anal Tox. 1989;13: 305-6.
28. Horak BS, Jenkins AJ. Postmortem tissue distribution of olanzapine and citalopram in a drug intoxication. J Forensic Sci. 2005;50: 679-81.
29. Shields LBE, Hunsaker JC III, Corey TS, Ward MK, Stewart D. Methadone toxicity fatalities: a review of medical examiner cases in a large metropolitan area. J Forensic Sci. 2007;52: 1389-95.
30. Milroy CM, Forrest ARW. Methadone deaths: a toxicological analysis. J Clin Path. 2000;53: 277-81.
31. Linnet K, Johansen SS, Buchard A, Mukholm J, Morling N. Dominance of pre-analytical over analytical variation for measurement of methadone and its main metabolite in postmortem femoral blood. Forensic Sci Int. 2008;179: 78-82.
32. Levine B, Jufer RA, Smialek JE. Lamotrigine distribution in two postmortem cases. J Anal Tox. 2000;24: 635-7.
33. Pricone MG, King CV, Drummer OH, Opeskin K, McIntyre IM. Postmortem investigation of lamotrigine concentrations. J Forensic Sci. 2000;45: 11-5.
34. Moore KA, Levine B, Smith ML, Saki S, Schames J, Smialek JE. Tissue distribution of mirtazapine (remeron) in postmortem cases. J Anal Tox. 1999;23: 541-3.
35. Anderson DT, Fritz KL, Muto JJ. Distribution of mirtazapine (remeron) in thirteen postmortem cases. J Anal Tox. 1999;23: 544-8.
36. Musshoff F, Madea B. Fatality due to ingestion of tramadol alone. Forensic Sci Int. 2001;16: 197-9.
37. Michaud K, Augsburger M, Romain N, Giroud C, Mangin P. Fatal overdose of tramadol and alprazolam. Forensic Sci Int. 1999;105: 185-9.
38. DeDecker K, Coronnier J, Jacobs W, Coucke V, Schepens P, Jorens PG. Fatal intoxication due to tramadol alone case report and review of the literature. Forensic Sci Int. 2008;175: 79-82.
39. Fu K, Konrad RJ, Hardy RW, Brissie RM, Robinson CA. An unusual multiple drug intoxication case Involving citalopram. J Anal Tox. 2000;24: 648-50.
40. Levine B, Zhang X, Smialek J. Citalopram distribution in postmortem cases. J Anal Tox. 2001;25: 641-644.
41. Jenkins AJ, Gubanich K. Disposition of citalopram in biological specimens from postmortem cases. J Forensic Sci. 2002;47: 159-64.
42. Anastos N, McIntyre IM, Lynch MJ, Drummer OH. Postmortem concentrations of citalopram. J Forensic Sci. 2002;47: 882-4.
43. Levine B, Wu SC, Dixon A, Smialek JE. Site dependence of postmortem blood methadone concentrations. Am J Forensic Med Path. 1995;6: 97-100.
44. Chue P, Singer P. A review of olanzapine-associated toxicity and fatality in overdose. J Psych Neurosci. 2003;28: 253-62.
45. Merrick TC, Felo JA, Jenkins AJ. Tissue distribution of olanzapine in a postmortem case. Am J Forensic Med Path. 2001;22: 270-4.
46. Vance C, McIntyre IM. Postmortem tissue concentrations of olanzapine. J Anal Tox. 2009;33: 15-26.
47. Levine B, Jenkins AJ, Queen M, Jufer R, Smialek JE. Distribution of venlafaxine in three postmortem cases. J Anal Tox. 1996;20: 502-5.
48. Parsons A, Anthony R, Meeker J. Two fatal cases of venlafaxine poisoning. J AnalTox. 1996;20: 266-8.
49. Flammia DD, Valouch T, Venuti S. Tissue distribution of quetiapine in 20 cases in Virginia. J Anal Tox. 2006;30: 287-92.
50. Wise S, Jenkins AJ. Disposition of quetiapine in biological specimens from postmortem cases. J Forensic Sci. 2005;50: 209-14.
51. Langford AM, Pounder DJ. Possible markers for postmortem drug redistribution. J Forensic Sci. 1997;42: 88-92.
52. McIntyre IM, Mallett P. Sertraline concentrations and postmortem redistribution. Forensic Sci Int. 2012;223: 349-52.